Small molecules in oncology
Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of personalized cancer therapy is now growing rapidly, and the progress being made will result in significant changes in the treatment algorithms for cancer patients. Numerous novel targe...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Edited Volume |
| Language: | English |
| Published: |
Berlin, Heidelberg s.l.
Springer Berlin Heidelberg Imprint: Springer
2014
|
| Edition: | 2nd ed. 2014 |
| Series: | Recent results in cancer research
201 |
| In: |
Recent results in cancer research (201)
|
| Volumes / Articles: | Show Volumes / Articles. |
| DOI: | 10.1007/978-3-642-54490-3 |
| Subjects: | |
| Online Access: | Verlag, Volltext: https://doi.org/10.1007/978-3-642-54490-3 Resolving-System, lizenzpflichtig, Volltext: http://dx.doi.org/10.1007/978-3-642-54490-3 Cover: https://swbplus.bsz-bw.de/bsz405482620cov.jpg 
|
| Author Notes: | edited by Uwe M. Martens |
Table of Contents:
- Imatinib MesylateErlotinib
- Axitinib (AG-013736)
- Lapatinib
- Sorafenib
- Sunitinib
- Dasatinib
- Nilotinib
- Bosutinib
- Decitabine
- Azacytidine/Azacitidine
- Bortezomib
- Temsirolimus
- Danusertib
- Vismodegib
- Everolimus
- Vemurafenib
- Vandetanib
- Trametinib
- Dabrafenib
- Ponatinib
- Regorafenib
- Cabozantinib
- Revlimid
- Ibrutinib
- Qizartinib
- Ruxolitinib
- Carfilzomib
- Afitinib.